mercredi 20 mai 2020


Storms and floods are complicating efforts to keep people safe from the virus.
May 20, 2020
An informed guide to the global outbreak, with the latest developments and expert advice about prevention and treatment.

(Was this email forwarded to you? Sign up here.)
The New York Times



Disasters complicate pandemics, and vice versa.


The flooding in Central Michigan and the powerful cyclone plowing into South Asia are showing us how the measures we take to be safe from one kind of calamity can heighten our danger from another.
When a dam bursts or a ferocious storm bears down, the people in harm’s way must evacuate their homes and find shelter — the opposite of staying at home and maintaining social distancing. So fleeing the flood exposes you to the coronavirus, and fleeing the coronavirus exposes you to the flood.

Cyclone Amphan, one of the strongest Indian Ocean storms in decades, slammed into the east coast of India on Wednesday and menaced Bangladesh. Both countries are densely populated, and both are under lockdown orders.
More than three million people living in swampy coastal areas of the two nations evacuated to emergency cyclone shelters. But some of the shelters were only half-full, because of widespread fear of packing into places where the virus could spread easily.

And in Michigan, after two dams on the Tittabawassee River failed on Tuesday, Gov. Gretchen Whitmer implored residents to evacuate immediately — but also to keep following social-distancing precautions, which she acknowledged would not be easy in shelters.
“To go through this in the midst of a global pandemic is almost unthinkable,” the governor said. “But we are here, and to the best of our ability, we are going to navigate this together.”

At a high school in Midland, Mich., volunteers in masks set up cots and air mattresses six feet apart, encouraged people to sanitize their hands every two hours and frequently wiped down surfaces with disinfectant, The Detroit Free Press reported.
“Everything is just so weird right now,” one evacuee at the school told the paper. “I’m just waiting for the meteor.”

The Times is providing free access to much of our coronavirus coverage, and our Coronavirus Briefing newsletter — like all of our newsletters — is free. Please consider supporting our journalism with a subscription.

New York City hospitals enter a new phase


New York City hospitals have seen a sharp drop in coronavirus patients and have begun to transition to the next stage in their fight against the outbreak.
Our correspondent Sheri Fink has covered the pandemic from inside the city’s hospitals since the beginning. We asked her about the new reality.

What is the biggest change you’ve seen?
Right now, the big noticeable change is in the emergency rooms. All the staff is covered in protective gear, filling the emergency room, and there are very few patients.

How have staff members been faring emotionally?
There’s this strange thing happening where everyone is thanking them and clapping for them, but they are grappling with guilt because they couldn’t save everybody. Doctors, nurses and hospital staff are used to life and death, but they’re not used to death on this scale, and they’re not used to feeling so helpless.

What are the hospitals up against now?
They’re facing a number of challenges. They can’t start elective surgeries because of an executive order from the governor that currently bans them — and that affects the bottom line. They’re also concerned that people aren’t coming to their clinics, so they face this challenge of convincing the public that it’s safe. And also, they don’t know what lies ahead. There are a lot of people who are convinced that there’s going to be a second wave in the fall, or even mini-waves. So they’re having to prepare for every scenario, while they are still grappling with the previous ones.

The hurdles in the race for a vaccine



More than 100 research teams are working on vaccines for the coronavirus, with early results offering hope that one will be released in record time — perhaps sometime next year. But finding a safe, effective vaccine is just part of the puzzle: It also has to be produced and distributed.
Manufacturing vaccines is very complex, and no single company will be able to meet the global demand. And along with a vaccine — or better, several — we’ll also need all of the necessary supplies, like syringes, vials and bandages; shortages of any of them could create a bottleneck, too.

One thing the European Union hopes won’t get in the way: fights over intellectual property rights. The union has proposed a voluntary pool for sharing vaccine patents.
Getting closer: A prototype vaccine has been found to protect monkeys from the coronavirus, and may point the way to effective human vaccines.

Different routes: Scientists are taking at least four main approaches to developing a vaccine, some well established (they worked for diseases like chickenpox and measles) and others still highly experimental.
Curbed enthusiasm: News of a small but promising human trial for a vaccine developed by a biotech company, Moderna, lifted hopes and stock markets this week. But several vaccine experts told the medical news site Stat that it was all but impossible to assess the findings because the company had released very little information.

Reopenings




What you can do

Increase your internet speed. Our Tech Fix columnist explains how to diagnose and, when possible, fix a lousy connection. One tip: If your router is more than five years old, it should be replaced.

Take a cue from Times journalists. Our reporters, critics and editors have started Google Docs with their quarantine recommendations. Check out the horrors movies they’re watching, the books they’re buying and the food they’re cooking.
Go camping at home. If you have a backyard, throw up a tent, roast s’mores over a fire pit and enjoy the novelty of sleeping somewhere else — while still having access to your own bathrooms.

What else we’re following



What you’re doing




Let us know how you’re dealing with the outbreak. Send us a response here, and we may feature it in an upcoming newsletter.

Lara Takenaga and Jonathan Wolfe helped write today’s newsletter.
Email your thoughts to briefing@nytimes.com. Did a friend forward you the briefing? Sign up here.


Aucun commentaire:

Enregistrer un commentaire